- Home
- Industry Reports
- Diagnostics
- Healthcare
- Point-of-care Diagnostic Market- Size, Outlook, Trends and Forecast (2024 – 2032)
Point-of-care testing is medical diagnostic testing or near point-of-care testing. Point-of-care tests are simple medical tests that are performed and develop new technology to mask the complexity. Connectivity is an important part of the point-of-care market. North America is accounting for the most significant market share.
Point-of-care Diagnostic Market Segments size & growth:
The market is valued at USD 25.92 billion in 2017 and is projected to USD 45.24 billion by 2024 at a CAGR of 10.0%. The significant factors that are driving the growth of the market are the increase in awareness and inclination towards home health care, and prevalence of lifestyle and infectious disease and demand for the market is expected to grow in the further years. Rapid growth in ageing population, advancements in technology and increase in some chronic diseases.
Point-of-care Diagnostic Market Share:
Point-of-care diagnostics market is categorised by by-product, mode of delivery and end user. By by-product, it is segmented into infectious disease, glucose monitoring kit, oncology markers, coagulation, drugs of abuse and blood gas testing and others. Based on the mode of delivery the market is categorised into OTC testing and prescription. And based on end users the market is segmented into research laboratories, home health care, and hospitals. As by-product categorises the market, mode of delivery and end user the market equally constitutes the market share in all the categories like hospitals, research laboratories and home health care, testing and monitoring. Geographically, North America is accounting for largest share for point-of-care followed by Europe. Asia-Pacific is the fastest growing segment and exhibits strong growth rate during the forecast (2018-24)
Point-of-care Diagnostic Market Trends:
- Roche, Alere, Abbott, and Siemens are the ones which are the largest companies regarding point-of-care diagnostics market revenues and these companies together make three-fourths of entire POC diagnostics market.
- Waltham, MA-based Alere secured the second market position and participated in nearly all the POC segments but dominates in cardiac markers.
Point-of-care Diagnostic Market Research Reports Include:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by the analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
- Abbott Laboratories
- Siemens AG
- Johnson & Johnson
- Alere Inc.
- Nova Biomedical
- Roche Diagnostics
1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing prevalence of chronic and infectious diseases.
4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness.
4.1.3 Technological advancements and adoption of a home-based point of care devices and new product launches.
4.1.4 Increase in worldwide expenditures on healthcare.
4.1.5 Increase in usage of home-based POC devices due to the shortage of skilled laboratory technicians.
4.2 Restraints
4.2.1 Lack of coordination among organisations (healthcare).
4.2.2 High procedure costs.
4.2.3 Inadequate reimbursement policies for point of care diagnostics devices.
4.2.4 Product prices and hampering profits.
4.2.5 Time-consuming policies, therefore, increasing gestation period for product launches.
4.3 Opportunities
4.3.1 Miniaturization of testing devices.
4.3.2 Developing economies after lucrative growth opportunities and increasing number of conferences and events.
4.4 Challenges
4.4.1 Irresponsible towards the change of treatment practices.
4.4.2 Lack of professionals and lack of knowledge on POC devices.
5. Point of Care Diagnostics Market – By Product
5.1 Introduction
5.2 Infectious diseases
5.3 Cardio metabolic kits
5.4 Glucose monitoring kits
5.5 Oncology markers
5.6 Coagulation
5.7 Urinalysis
5.8 OTC diagnostics test
5.9 Drugs of abuse
5.10 Blood gas testing
5.11 Fertility testing
5.12 Others
6. Point of Care Diagnostics Market – By mode of delivery
6.1 Introduction
6.2 OTC testing
6.3 Prescription
7. Point of Care Diagnostics Market – By End-user
7.1 Introduction
7.2 Hospitals
7.3 Research laboratories
7.4 Home healthcare
7.5 Others
8. Point of Care Diagnostics Market – By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 United Kingdom
8.2.6 Spain
8.2.7 Russia
8.2.8 Others
8.3 Asia-pacific
8.3.1 Introduction
8.3.2 China
8.3.3 Japan
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 the Middle East and Africa
8.5.1 Introduction
8.5.2 Middle East
8.5.3 Africa
9 Point of Care Diagnostics – Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted by Top Companies
10. Point of Care Diagnostics – Company Profiles
10.1 Roche diagnostics
10.2 Abbott Laboratories
10.3 Siemens AG
10.4 Johnson & Johnson
10.5 Alere Inc.
10.6 Nova biomedical
10.7 Instrumentation laboratory
10.8 PTs diagnostics
10.9 Beckman Coulter, Inc.
10.10 Becton, Dikinson & Company
10.11 Agendia
10.12 Hologic
10.13 Cephied
10.14 Illumina
10.15 Bayer AG
10.16 Danaher Corporation
10.17 Genomic health
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,500.93 - €7,502.78
- INR: ₹225,483.51 - ₹676,450.54
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,150.37 - £6,451.11
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Point-of-care testing is medical diagnostic testing or near point-of-care testing. Point-of-care tests are simple medical tests that are performed and develop new technology to mask the complexity. Connectivity is an important part of the point-of-care market. North America is accounting for the most significant market share.
Point-of-care Diagnostic Market Segments size & growth:
The market is valued at USD 25.92 billion in 2017 and is projected to USD 45.24 billion by 2024 at a CAGR of 10.0%. The significant factors that are driving the growth of the market are the increase in awareness and inclination towards home health care, and prevalence of lifestyle and infectious disease and demand for the market is expected to grow in the further years. Rapid growth in ageing population, advancements in technology and increase in some chronic diseases.
Point-of-care Diagnostic Market Share:
Point-of-care diagnostics market is categorised by by-product, mode of delivery and end user. By by-product, it is segmented into infectious disease, glucose monitoring kit, oncology markers, coagulation, drugs of abuse and blood gas testing and others. Based on the mode of delivery the market is categorised into OTC testing and prescription. And based on end users the market is segmented into research laboratories, home health care, and hospitals. As by-product categorises the market, mode of delivery and end user the market equally constitutes the market share in all the categories like hospitals, research laboratories and home health care, testing and monitoring. Geographically, North America is accounting for largest share for point-of-care followed by Europe. Asia-Pacific is the fastest growing segment and exhibits strong growth rate during the forecast (2018-24)
Point-of-care Diagnostic Market Trends:
- Roche, Alere, Abbott, and Siemens are the ones which are the largest companies regarding point-of-care diagnostics market revenues and these companies together make three-fourths of entire POC diagnostics market.
- Waltham, MA-based Alere secured the second market position and participated in nearly all the POC segments but dominates in cardiac markers.
Point-of-care Diagnostic Market Research Reports Include:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by the analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
- Abbott Laboratories
- Siemens AG
- Johnson & Johnson
- Alere Inc.
- Nova Biomedical
- Roche Diagnostics
1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing prevalence of chronic and infectious diseases.
4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness.
4.1.3 Technological advancements and adoption of a home-based point of care devices and new product launches.
4.1.4 Increase in worldwide expenditures on healthcare.
4.1.5 Increase in usage of home-based POC devices due to the shortage of skilled laboratory technicians.
4.2 Restraints
4.2.1 Lack of coordination among organisations (healthcare).
4.2.2 High procedure costs.
4.2.3 Inadequate reimbursement policies for point of care diagnostics devices.
4.2.4 Product prices and hampering profits.
4.2.5 Time-consuming policies, therefore, increasing gestation period for product launches.
4.3 Opportunities
4.3.1 Miniaturization of testing devices.
4.3.2 Developing economies after lucrative growth opportunities and increasing number of conferences and events.
4.4 Challenges
4.4.1 Irresponsible towards the change of treatment practices.
4.4.2 Lack of professionals and lack of knowledge on POC devices.
5. Point of Care Diagnostics Market – By Product
5.1 Introduction
5.2 Infectious diseases
5.3 Cardio metabolic kits
5.4 Glucose monitoring kits
5.5 Oncology markers
5.6 Coagulation
5.7 Urinalysis
5.8 OTC diagnostics test
5.9 Drugs of abuse
5.10 Blood gas testing
5.11 Fertility testing
5.12 Others
6. Point of Care Diagnostics Market – By mode of delivery
6.1 Introduction
6.2 OTC testing
6.3 Prescription
7. Point of Care Diagnostics Market – By End-user
7.1 Introduction
7.2 Hospitals
7.3 Research laboratories
7.4 Home healthcare
7.5 Others
8. Point of Care Diagnostics Market – By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 United Kingdom
8.2.6 Spain
8.2.7 Russia
8.2.8 Others
8.3 Asia-pacific
8.3.1 Introduction
8.3.2 China
8.3.3 Japan
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 the Middle East and Africa
8.5.1 Introduction
8.5.2 Middle East
8.5.3 Africa
9 Point of Care Diagnostics – Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted by Top Companies
10. Point of Care Diagnostics – Company Profiles
10.1 Roche diagnostics
10.2 Abbott Laboratories
10.3 Siemens AG
10.4 Johnson & Johnson
10.5 Alere Inc.
10.6 Nova biomedical
10.7 Instrumentation laboratory
10.8 PTs diagnostics
10.9 Beckman Coulter, Inc.
10.10 Becton, Dikinson & Company
10.11 Agendia
10.12 Hologic
10.13 Cephied
10.14 Illumina
10.15 Bayer AG
10.16 Danaher Corporation
10.17 Genomic health
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.